Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer

Head and Neck

Volumn 36, Issue 4, 2014, Pages 499-504

  Lee, Hyebin ^a   Ahn, Yong Chan ^a   Oh, Dongryul ^a   Nam, Heerim ^a   Kim, Young Il ^a   Park, Su Yeon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

adaptive therapy; oropharyngeal cancer; radiation therapy; tumor volume

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TREATMENT FAILURE; TUMOR VOLUME; TUMOR VOLUME REDUCTION RATE;

ADAPTIVE THERAPY; OROPHARYNGEAL CANCER; RADIATION THERAPY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIMODAL IMAGING; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896110426     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23328     Document Type: Article

References (19)

1. Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004; 15: 1179-1186.
2. Soo KC, Tan EH, Wee J, et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005; 93: 279-286.
3. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69-76.
4. Jaffe CC,. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 2006; 24: 3245-3251.
5. Perez CA, Patel MM, Chao KS, et al. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys 1998; 42: 1077-1084.
6. Johansen LV, Grau C, Overgaard J,. Squamous cell carcinoma of the oropharynx-an analysis of treatment results in 289 consecutive patients. Acta Oncol 2000; 39: 985-994.
7. Mancuso AA, Mukherji SK, Schmalfuss I, et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999; 17: 631-637.
8. Pameijer FA, Mancuso AA, Mendenhall WM, et al. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck 1998; 20: 159-168.
9. Chua DT, Sham JS, Kwong DL, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997; 39: 711-719.
10. Nathu RM, Mancuso AA, Zhu TC, Mendenhall WM,. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck 2000; 22: 1-5.
11. Hermans R, Op de beeck K, Van den Bogaert W, et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2001; 50: 37-45.
12. Lok BH, Setton J, Caria N, et al. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. Int J Radiat Oncol Biol Phys 2012; 82: 1851-1857.
13. Nam H, Park W, Huh SJ, et al. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 2007; 107: 320-325.
14. Yeo SG, Kim DY, Park JW, et al. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2012; 82: e193-e199.
15. Bral S, De Ridder M, Duchateau M, et al. Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome. Int J Radiat Oncol Biol Phys 2011; 80: 1338-1342.
16. Barker JL Jr, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004; 59: 960-970.
17. Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P,. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 64: 355-362.
18. Bhide SA, Davies M, Burke K, et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys 2010; 76: 1360-1368.
19. Zhao L, Wan Q, Zhou Y, Deng X, Xie C, Wu S,. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol 2011; 98: 23-27.